The dual role of ferroptosis in anthracycline-based chemotherapy includes reducing resistance and increasing toxicity
Authors:
Open Access
- 21 June 2023
- journal article
- review article
- Published by Springer Nature in Cell Death Discovery
- Vol. 9 (1) , 1-12
Abstract
In conjunction with previous studies, we have noted that ferroptosis, as an emerging mode of regulated cell death (RCD), is intimately related to anthracycline pharmacotherapy. Not only does ferroptosis significantly modulate tumour resistance and drug toxicity, which are core links of the relevant chemotherapeutic process, but it also appears to play a conflicting role that has yet to be appreciated. By targeting the dual role of ferroptosis in anthracycline-based chemotherapy, this review aims to focus on the latest findings at this stage, identify the potential associations and provide novel perspectives for subsequent research directions and therapeutic strategies.Keywords
Funding Information
- Industry-University-Research Innovation Fund of the Science and Technology Development Center, Ministry of Education, China
- Hebei Natural Science Foundation
This publication has 153 references indexed in Scilit:
- Ferroptosis: An Iron-Dependent Form of Nonapoptotic Cell DeathCell, 2012
- Effect of stable inhibition of NRF2 on doxorubicin sensitivity in human ovarian carcinoma OV90 cellsArchives of Pharmacal Research, 2010
- Acquisition of doxorubicin resistance in ovarian carcinoma cells accompanies activation of the NRF2 pathwayFree Radical Biology and Medicine, 2009
- Interaction of anthracyclines with iron responsive element mRNAsNucleic Acids Research, 2008
- Dexrazoxane-Associated Risk for Acute Myeloid Leukemia/Myelodysplastic Syndrome and Other Secondary Malignancies in Pediatric Hodgkin's DiseaseJournal of Clinical Oncology, 2007
- Differential effects of dihydropyridine calcium antagonists on doxorubicin-induced nephrotoxicity in ratsToxicology, 2007
- Molecular Pharmacology of the Interaction of Anthracyclines with IronMolecular Pharmacology, 2005
- Transferrin Receptor-dependent Iron Uptake Is Responsible for Doxorubicin-mediated Apoptosis in Endothelial CellsJournal of Biological Chemistry, 2002
- Comparison of Different Iron Chelators as Protective Agents Against Acute Doxorubicin-induced CardiotoxicityJournal of Molecular and Cellular Cardiology, 1994
- Deferoxamine (Desferrioxamine) New Toxicities for an Old DrugDrug Safety, 1991